The ROE as of September 2024 (TTM) for Horizon Therapeutics Public Limited Company (HZNP) is 5.86%

According to Horizon Therapeutics Public Limited Company’s latest financial reports and current stock price. The company's current ROE is 5.86%. This represents a change of 174.36% compared to the average of 2.13% of the last 4 quarters.

Horizon Therapeutics Public Limited Company (HZNP) Historical ROE (quarterly & annually)

How has HZNP ROE performed in the past?

The mean historical ROE of Horizon Therapeutics Public Limited Company over the last ten years is 25.38%. The current 5.86% ROE has changed -76.92% with respect to the historical average. Over the past ten years (40 quarters), HZNP's ROE was at its highest in in the December 2013 quarter at 209.65%. The ROE was at its lowest in in the June 2014 quarter at -34.42%.

Horizon Therapeutics Public Limited Company (HZNP) ROE by Quarter and Year

Discovering the peaks and valleys of Horizon Therapeutics Public Limited Company ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Horizon Therapeutics Public Limited Company (HZNP) Average ROE

How has HZNP ROE performed in the past?

The current ROE of Horizon Therapeutics Public Limited Company (HZNP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Horizon Therapeutics Public Limited Company (HZNP) ROE vs. Peers

How is HZNP’s ROE compared to its peers?

Horizon Therapeutics Public Limited Company’s ROE is greater than Bristol-Myers Squibb Company (-28.46%), less than AbbVie Inc. (57.35%), less than Merck & Co., Inc. (33.75%), less than Gilead Sciences, Inc. (5.21%), less than Johnson & Johnson (54.01%), less than Amgen Inc. (50.41%), less than Eli Lilly and Company (60.72%), less than AstraZeneca PLC (16.80%), less than Sanofi (10.71%), less than Novartis AG (38.92%), less than GSK plc (29.50%), less than Roche Holding AG (54.68%),

Build a custom stock screener for Horizon Therapeutics Public Limited Company (HZNP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Horizon Therapeutics Public Limited Company using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Horizon Therapeutics Public Limited Company (HZNP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Horizon Therapeutics Public Limited Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.